Adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine: Findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea

Jong Hee Kim, Hee Yeon Cho, Karen A. Hennessey, Hoan Jong Lee, Geun Ryang Bae, Hyeon Chang Kim

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

This study characterized the adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine in Korea. Data on immunization and AEFI were collected between October 27, 2009 and March 15, 2010 through the national immunization registry and passive surveillance systems. The frequency of AEFI and serious adverse events (SAEs) were calculated according to age, sex, priority group, and vaccine type. In 13,758,527 vaccine recipients aged 6 months or older, 2,530 AEFI were reported (18.4 per 100,000 immunizations). The AEFI reporting rate was highest among people aged 10-19 years (29.6 per 100,000 immunizations) and was higher in female recipients than in male recipients (20.0 versus 16.7 per 100,000 immunizations). Most AEFIs were nonspecific systematic reactions that occurred within 24 h (77.4z) after vaccine administration. A total of 178 vaccinerelated SAEs were identified, and vaccine-related mortalities were not reported. This study showed that the AEFI reporting rate after influenza A (H1N1) 2009 vaccinations was relatively high, especially in the younger population. Mild systemic reactions accounted for the majority of reported AEFI, and fatal SAEs were rare. This study also implied that passive surveillance might be an efficient safety monitoring system that can detect relatively rare AEFI.

Original languageEnglish
Pages (from-to)99-104
Number of pages6
JournalJapanese journal of infectious diseases
Volume65
Issue number2
Publication statusPublished - 2012 Apr 2

Fingerprint

Republic of Korea
Passive Immunization
Human Influenza
Registries
Immunization
Vaccines
Korea
Vaccination

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Infectious Diseases

Cite this

@article{84efeccb6b8d4c81a2c245931b754957,
title = "Adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine: Findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea",
abstract = "This study characterized the adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine in Korea. Data on immunization and AEFI were collected between October 27, 2009 and March 15, 2010 through the national immunization registry and passive surveillance systems. The frequency of AEFI and serious adverse events (SAEs) were calculated according to age, sex, priority group, and vaccine type. In 13,758,527 vaccine recipients aged 6 months or older, 2,530 AEFI were reported (18.4 per 100,000 immunizations). The AEFI reporting rate was highest among people aged 10-19 years (29.6 per 100,000 immunizations) and was higher in female recipients than in male recipients (20.0 versus 16.7 per 100,000 immunizations). Most AEFIs were nonspecific systematic reactions that occurred within 24 h (77.4z) after vaccine administration. A total of 178 vaccinerelated SAEs were identified, and vaccine-related mortalities were not reported. This study showed that the AEFI reporting rate after influenza A (H1N1) 2009 vaccinations was relatively high, especially in the younger population. Mild systemic reactions accounted for the majority of reported AEFI, and fatal SAEs were rare. This study also implied that passive surveillance might be an efficient safety monitoring system that can detect relatively rare AEFI.",
author = "Kim, {Jong Hee} and Cho, {Hee Yeon} and Hennessey, {Karen A.} and Lee, {Hoan Jong} and Bae, {Geun Ryang} and Kim, {Hyeon Chang}",
year = "2012",
month = "4",
day = "2",
language = "English",
volume = "65",
pages = "99--104",
journal = "Japanese Journal of Infectious Diseases",
issn = "1344-6304",
publisher = "National Institute of Health",
number = "2",

}

Adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine : Findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea. / Kim, Jong Hee; Cho, Hee Yeon; Hennessey, Karen A.; Lee, Hoan Jong; Bae, Geun Ryang; Kim, Hyeon Chang.

In: Japanese journal of infectious diseases, Vol. 65, No. 2, 02.04.2012, p. 99-104.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine

T2 - Findings from the national registry of all vaccine recipients and AEFI and the passive surveillance system in South Korea

AU - Kim, Jong Hee

AU - Cho, Hee Yeon

AU - Hennessey, Karen A.

AU - Lee, Hoan Jong

AU - Bae, Geun Ryang

AU - Kim, Hyeon Chang

PY - 2012/4/2

Y1 - 2012/4/2

N2 - This study characterized the adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine in Korea. Data on immunization and AEFI were collected between October 27, 2009 and March 15, 2010 through the national immunization registry and passive surveillance systems. The frequency of AEFI and serious adverse events (SAEs) were calculated according to age, sex, priority group, and vaccine type. In 13,758,527 vaccine recipients aged 6 months or older, 2,530 AEFI were reported (18.4 per 100,000 immunizations). The AEFI reporting rate was highest among people aged 10-19 years (29.6 per 100,000 immunizations) and was higher in female recipients than in male recipients (20.0 versus 16.7 per 100,000 immunizations). Most AEFIs were nonspecific systematic reactions that occurred within 24 h (77.4z) after vaccine administration. A total of 178 vaccinerelated SAEs were identified, and vaccine-related mortalities were not reported. This study showed that the AEFI reporting rate after influenza A (H1N1) 2009 vaccinations was relatively high, especially in the younger population. Mild systemic reactions accounted for the majority of reported AEFI, and fatal SAEs were rare. This study also implied that passive surveillance might be an efficient safety monitoring system that can detect relatively rare AEFI.

AB - This study characterized the adverse events following immunization (AEFI) with the novel influenza A (H1N1) 2009 vaccine in Korea. Data on immunization and AEFI were collected between October 27, 2009 and March 15, 2010 through the national immunization registry and passive surveillance systems. The frequency of AEFI and serious adverse events (SAEs) were calculated according to age, sex, priority group, and vaccine type. In 13,758,527 vaccine recipients aged 6 months or older, 2,530 AEFI were reported (18.4 per 100,000 immunizations). The AEFI reporting rate was highest among people aged 10-19 years (29.6 per 100,000 immunizations) and was higher in female recipients than in male recipients (20.0 versus 16.7 per 100,000 immunizations). Most AEFIs were nonspecific systematic reactions that occurred within 24 h (77.4z) after vaccine administration. A total of 178 vaccinerelated SAEs were identified, and vaccine-related mortalities were not reported. This study showed that the AEFI reporting rate after influenza A (H1N1) 2009 vaccinations was relatively high, especially in the younger population. Mild systemic reactions accounted for the majority of reported AEFI, and fatal SAEs were rare. This study also implied that passive surveillance might be an efficient safety monitoring system that can detect relatively rare AEFI.

UR - http://www.scopus.com/inward/record.url?scp=84859016405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859016405&partnerID=8YFLogxK

M3 - Article

C2 - 22446114

AN - SCOPUS:84859016405

VL - 65

SP - 99

EP - 104

JO - Japanese Journal of Infectious Diseases

JF - Japanese Journal of Infectious Diseases

SN - 1344-6304

IS - 2

ER -